Abstract | BACKGROUND: PATIENTS AND METHODS: RESULTS:
Stomatitis (Grade: > or = 3) developed in one of 11 patients in the polaprezinc group and in 4 of 8 patients in the control group(P = 0.046). The times at which stomatitis development ranged between weeks 1 and 2 after the onset of TBI in the two groups. No adverse reaction owing to the ingestion of P-CMC was observed. CONCLUSIONS:
|
Authors | Fujiwara Masayuki, Kamikonya Norihiko, Tsuboi Keita, Irie Miwa, Izumi Masayuki, Irie Toshihiko, Fujisawa Hiromi, Muro Chikaaki, Nakao Norio |
Journal | Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica
(Nihon Igaku Hoshasen Gakkai Zasshi)
Vol. 62
Issue 4
Pg. 144-50
(Mar 2002)
ISSN: 0048-0428 [Print] Japan |
PMID | 12043217
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Ulcer Agents
- Organometallic Compounds
- Zinc Compounds
- polaprezinc
- Carnosine
|
Topics |
- Adult
- Anti-Ulcer Agents
(therapeutic use)
- Carnosine
(analogs & derivatives, therapeutic use)
- Female
- Humans
- Male
- Organometallic Compounds
(therapeutic use)
- Radiation Injuries
(prevention & control)
- Stomatitis
(prevention & control)
- Whole-Body Irradiation
(adverse effects)
- Zinc Compounds
|